The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: Results from a global multi-site chart review.
 
XiangLin Tan
Employment - Merck
Stock and Other Ownership Interests - Merck
Research Funding - Merck
Travel, Accommodations, Expenses - Merck
 
Ryan Sullivan
Consulting or Advisory Role - BridGene Biosciences; Bristol-Myers Squibb; Marengo Therapeutics; Merck; Novartis; Pfizer; Replimune
Research Funding - Aeglea Biotherapeutics (Inst); Amgen (Inst); Asana Biosciences (Inst); BeiGene (Inst); BioMed Valley Discoveries (Inst); Compugen (Inst); Deciphera (Inst); Georgimmune (Inst); Lilly (Inst); Marengo Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Neon Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); Rubius Therapeutics (Inst); Sanofi (Inst); Strategia (Inst); Strategia (Inst); Synthekine (Inst); Viralytics (Inst)
 
Kavita Gandhi Morar
Research Funding - OXON Epidemiology
 
Alicia Delibes
Research Funding - OXON Epidemiology
 
Ignacio Méndez
Research Funding - OXON Epidemiology
 
Ruixuan Jiang
Employment - Merck & Co., Inc.,
Stock and Other Ownership Interests - Merck & Co., Inc.,
 
Clemens Krepler
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Elizabeth Gaughan
Research Funding - Bristol Myers Squibb Foundation (Inst); Iovance Biotherapeutics (Inst); Ludwig Institute for Cancer Research (Inst); MapKure (Inst); Merck (Inst); OnKure (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Iovance Biotherapeutics; Regeneron
 
Aparna Rao
Research Funding - Merck (Inst)
 
James Isaacs
Research Funding - Bristol-Myers Squibb/Medarex (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); TScan Therapeutics (Inst); Vaxiion Therapeutics (Inst)
 
Marcin Dzienis
Honoraria - AstraZeneca; MSD; Novartis
Consulting or Advisory Role - BMS; MSD; Novartis
Travel, Accommodations, Expenses - MSD
 
Maria Wei
Research Funding - Merck (Inst)
 
Xiaochen Zhong
Research Funding - Merck (Inst)
 
Alexandra So
Research Funding - Merck (Inst)
 
Miso Kim
Honoraria - Astellas Pharma; Bristol Myers Squibb; Janssen; Merck; Ono Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; Bayer; Boehringer Ingelheim; Boryung; Bristol-Myers Squibb; Janssen; Merck; MSD; Ono Pharmaceutical; Pfizer; Takeda; Yuhan
Travel, Accommodations, Expenses - Regeneron
 
Yu Jung Kim
Research Funding - Amgen (Inst); AstraZeneca (Inst); BMS (Inst); Bridge Biotherapeutics (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); Janssen (Inst); Lilly (Inst); MSD (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)
 
Ryan Weight
Consulting or Advisory Role - Immunocore, Regeneron, Castle Biosciences, BMS, Merck
Speakers' Bureau - Immunocore, Regeneron, Castle Biosciences, BMS, Merck
Patents, Royalties, Other Intellectual Property - Photoacoustic Detection of Circulating Analytes
 
Nawab Qizilbash
Research Funding - OXON Epidemiology
 
Irene Shui
Employment - Merck
Stock and Other Ownership Interests - Merck; Sanofi
Research Funding - Merck
Travel, Accommodations, Expenses - Merck